LifeMD CFO Atul Kavthekar files Form 3

LifeMD, Inc. filed an initial insider ownership report on SEC Form 3 for Atul Kavthekar, who serves as Chief Financial Officer.

Rhea-AI Filing Summary

LifeMD, Inc. filed an initial insider ownership report on SEC Form 3 for Atul Kavthekar, who serves as Chief Financial Officer. The filing identifies him as a reporting person but shows no buy, sell, exercise, gift, tax-withholding, or other transactions, with all transaction counts and share totals at zero in this excerpt.

Key Figures

Buy transactions: 0 transactions Sell transactions: 0 transactions Net buy/sell shares: 0 shares

3 metrics

Buy transactions 0 transactions buyCount in transaction summary

Sell transactions 0 transactions sellCount in transaction summary

Net buy/sell shares 0 shares netBuySellShares reported as neutral

Key Terms

Form 3, reportingPersons, Chief Financial Officer

3 terms

Form 3 regulatory

""form_type": "3""

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reportingPersons regulatory

""reportingPersons": [ { "name": "Kavthekar Atul""

Chief Financial Officer financial

""officer_title": "Chief Financial Officer""

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does LifeMD (LFMD) disclose in Atul Kavthekar’s Form 3 filing?

The Form 3 for LifeMD, Inc. lists Chief Financial Officer Atul Kavthekar as a reporting person. The transaction summary in this excerpt shows zero buys, zero sells, zero exercises, and no other insider share transactions or holdings reported.

Are any LifeMD (LFMD) insider share purchases or sales reported for Atul Kavthekar?

No insider share purchases or sales are reported for Atul Kavthekar in this Form 3 excerpt. The transaction summary shows 0 buyShares, 0 sellShares, and a netBuySellDirection described as neutral, indicating no trading activity disclosed here.

Does LifeMD’s Form 3 for Atul Kavthekar show any option exercises or derivative transactions?

The excerpted Form 3 does not show any option exercises or derivative transactions. It lists an exerciseCount of 0, exerciseShares of 0, and a derivativeTransactionCount of 0, with an empty derivativeSummary table, indicating no such activity reported.

What role does Atul Kavthekar hold at LifeMD (LFMD) in this Form 3?

In this Form 3, Atul Kavthekar is identified as an officer of LifeMD, Inc. with the title Chief Financial Officer. He is not listed as a director and is not marked as a ten percent owner in the reportingPersons section.

Does the LifeMD (LFMD) Form 3 excerpt show any indirect holdings or restructuring transactions?

The excerpted Form 3 does not indicate indirect holdings or restructuring activity. It shows restructuringCount and restructuringShares as 0, and holdingEntries is also 0, suggesting no reported restructuring-related or other recorded holdings in this data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/01/2026 - 05:31 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kavthekar Atul

(Last) (First) (Middle)

C/O LIFEMD

236 FIFTH AVENUE, SUITE 400

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc. [ LFMD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Atul Kavthekar	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)